The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include growing specialized medicines and wide application of genomics in numerous areas. Genomics is the branch of science that concerned with the structure, function, evolution, and mapping of genomes. Various steps are taken such as sampling, sequencing, data analysis and interpretation procedures to decode, assemble, and analyze genomes. Nowadays, people are diagnosed with genetic as well as chronic diseases due to which demand for personalized medicine is surging, which is bolstering the growth of the market. The other factors supporting the market's growth are, advancement in diagnostic techniques, increasing investments by governments, surge in cancer incidents and rise in R&D initiatives.
Increasing Demand of Specialized/Personalized Medicine
Growing Application of Genomics in Various Sectors
Technological Advancements
Download Free Sample Report
Market Segmentation
Market Players
Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., 23andMe, Inc., Eppendorf AG, and Quest Diagnostics Inc.
Attribute | Details |
Base Year | 2021 |
Historic Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends |
Segments covered | · Products & Services · Technology · Application · End User · Company |
Regional scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa |
Key companies profiled | Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., 23andMe, Inc., Eppendorf AG, and Quest Diagnostics Inc. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |